Alimera Sciences, Inc. (ALIM) Starts Presentation at the 8th Annual LD Micro Invitational
Alimera Sciences, Inc. (NASDAQ: ALIM), founded in June 2003, is a global pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharmaceuticals. The company’s focus is on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and will affect millions of people in aging populations. Alimera's commitment to retina specialists and their patients is manifest in its product portfolio. For more information, visit the company’s website at www.AlimeraSciences.com. About NetworkNewsWire NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers,…







